CONMED Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2074101013
USD
35.94
-1.4 (-3.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Globus Medical, Inc.
Sotera Health Co.
Haemonetics Corp.
CONMED Corp.
Merit Medical Systems, Inc.
Envista Holdings Corp.
Glaukos Corp.
Sanmina Corp.
Neogen Corp.
Integra LifeSciences Holdings Corp.
Inari Medical, Inc.

Why is CONMED Corp. ?

1
Poor long term growth as Operating profit has grown by an annual rate 18.38% of over the last 5 years
2
The company has declared negative results in Mar'2025 after 3 consecutive positive quarters
  • NET PROFIT(HY) At USD 27.05 MM has Grown at -45.97%
3
Below par performance in long term as well as near term
  • Along with generating -45.65% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to CONMED Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is CONMED Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
CONMED Corp.
-40.7%
-1.07
43.44%
S&P 500
14.9%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.82%
EBIT Growth (5y)
12.68%
EBIT to Interest (avg)
3.03
Debt to EBITDA (avg)
5.39
Net Debt to Equity (avg)
0.88
Sales to Capital Employed (avg)
0.69
Tax Ratio
18.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.55%
ROE (avg)
7.82%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.19
EV to EBIT
14.58
EV to EBITDA
10.29
EV to Capital Employed
1.11
EV to Sales
1.48
PEG Ratio
NA
Dividend Yield
99.91%
ROCE (Latest)
7.60%
ROE (Latest)
6.65%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 170.69 MM

DEBT-EQUITY RATIO (HY)

Lowest at 81.95 %

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

NET PROFIT(Q)

At USD 34.07 MM has Grown at 92.77%

RAW MATERIAL COST(Y)

Fallen by -7.63% (YoY

CASH AND EQV(HY)

Highest at USD 79.75 MM

NET SALES(Q)

Highest at USD 373.47 MM

OPERATING PROFIT(Q)

Highest at USD 85.72 MM

OPERATING PROFIT MARGIN(Q)

Highest at 22.95 %

PRE-TAX PROFIT(Q)

Highest at USD 59.54 MM

-9What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

NET PROFIT(HY)

At USD 41.6 MM has Grown at -32.89%

ROCE(HY)

Lowest at 4.72%

DIVIDEND PER SHARE(HY)

Lowest at USD 5.66

Here's what is working for CONMED Corp.

Operating Cash Flow
Highest at USD 170.69 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit
At USD 59.54 MM has Grown at 149.91%
over average net sales of the previous four periods of USD 23.83 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 34.07 MM has Grown at 92.77%
over average net sales of the previous four periods of USD 17.67 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Debt-Equity Ratio
Lowest at 81.95 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Sales
Highest at USD 373.47 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 85.72 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 22.95 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 59.54 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Cash and Eqv
Highest at USD 79.75 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -7.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 18.85 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 18.85 MM has Grown at 44.16%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for CONMED Corp.

Dividend Payout Ratio
Lowest at 0% and Fallen
In each year in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

Dividend per share
Lowest at USD 5.66
in the last five years
MOJO Watch
Company is distributing lower dividend than previous years

DPS (USD)